Atopic Dermatitis/Non-Wet(sicca) Eczema
Conditions
Interventions
Mometasone Furoate Group:Topical use Mometasone Furoate,once per day
Mometasone Furoate plus Moisturizer Group:Use Mometasone Furoate, once per day
Use Moisturizer, once per day
Sponsors
Institute of dermatology, Chinese Academyof Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Males and females aged between 2 and 80 years; (2) Atopic Dermatitis/Non-Wet(sicca) Eczema defined by the Diagnostic criteria; (3) SCORAD<30; (4) Provide written informed consent and Willing and able to comply with all aspects of the protocol. If Under 18 years old, informed consent will be written by the legal guardian.
Exclusion criteria
Exclusion criteria: (1) Requires the system medication to control the disease; (2) Patients with skin lesions associated with other diseases that may affect the curative effect judgment; (3) Systemic biologic therapies within 4 weeks prior to randomization; (4) Ultraviolet therapy within 4 weeks prior to randomization; (5) Plan to use the following drugs, such as corticosteroids, antibiotics, immunosuppressants, immunomodulators agents, which may affect the efficacy evaluation during the study period; (6) patients who are allergic to any ingredient of the drug to be studied; (7) Pregnant or lactating females; (8) Any other situations not suitable for this study determined by the investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence rate;Median time to recurrence;SCORAD score;Eosinophil count; | — |
Countries
China
Contacts
Public ContactBaoxi Wang
Institute of Dermatology, Chinese Academy of Medical Sciences
Outcome results
None listed